Micelle-Loaded Oral Dissolvable Strips: A Novel Strategy to Enhance Bioavailability and Pharmacokinetics of Therapeutics
Abstract
Background: This review examines the technology and therapeutic potential of oral dissolvable strips (ODS) loaded with micellized active pharmaceutical ingredients (APIs) for improved systemic drug delivery. Oral dissolvable strips (ODS) have emerged as a convenient and patient friendly route for drug delivery; however, many APIs exhibit poor aqueous solubility and stability, limiting their therapeutic efficiency. Micellar nanocarriers embedded in ODS can overcome these limitations by improving the solubility, stability, pharmacokinetics, and bioavailability.
Objective: This review evaluates the integration of micelle technology with ODS platforms to improve systemic absorption and therapeutic performance of APIs, focusing on formulation advances, pharmacokinetic improvements, and translational challenges.
Methods: Peer-reviewed research articles, patents, and reviews related to micellized APIs and oral film drug delivery systems were analyzed to identify formulation strategies, physicochemical optimization approaches, and clinical implications for diverse APIs.
Results: Micelle-embedded oral films enable efficient delivery of hydrophobic drugs, produce faster absorption and achieve higher plasma concentrations than conventional oral routes. By improving patient compliance, minimizing toxicity, and protecting APIs from hepatic and gastrointestinal degradation, micelle/ODS systems significantly enhance bioavailability. Challenges exist with formulation variables such as micelle composition and film thickness which affect release kinetics, and optimization and stabilization of micellized APIs.
Conclusion: Integrating micellar nanotechnology with oral dissolvable strips represents a promising next-generation platform for effective, non-invasive, and patient-compliant oral drug delivery. This technology holds great potential for delivering prescription drugs, supplements, chemotherapeutics, and biologics. Future investigations should prioritize optimizing formulation strategies and scalable manufacturing processes, clarifying regulatory pathways, and designing clinical trials.
Keywords: micelle, oral dissolvable strip, bioavailability, pharmacokinetics, drug delivery
Keywords:
micelle, oral dissolvable strip, bioavailability, pharmacokinetics, drug deliveryDOI
https://doi.org/10.22270/jddt.v15i12.7441References
1. Alqahtani MS, Kazi M, Alsenaidy MA, Ahmad MZ. Advances in oral drug delivery. Front Pharmacol. 2021;12:618411. https://doi.org/10.3389/fphar.2021.618411 PMid:33679401 PMCid:PMC7933596
2. Loke YH, Tan ML, Khor SY. A comprehensive review of challenges in oral drug delivery systems and recent advancements in innovative design strategies. Curr Pharm Des. 2025;31(5):360-376. https://doi.org/10.2174/0113816128338560240923073357 PMid:39390835
3. Saxena A, Singh T. Oral dissolving films: a comprehensive review on recent perspectives and current approach to effective drug delivery. J Drug Deliv Ther. 2022;12(2):139-147. https://doi.org/10.22270/jddt.v12i2.5244
4. Shojaei AH. Buccal mucosa as a route for systemic drug delivery: a review. J Pharm Pharm Sci. 1998;1(1):15-30. https://doi.org/10.1023/A:1011927521627 PMid:9706047
5. Salawi A. An insight into preparatory methods and characterization of orodispersible films-a review. Pharmaceuticals. 2022;15(7):844. https://doi.org/10.3390/ph15070844 PMid:35890143 PMCid:PMC9323338
6. Bala R, Pawar P, Khanna S, Arora S. A new approach to oral drug delivery system. J Adv Pharm Technol Res. 2013;4(1):5-12. doi:10.4103/2231-4040.107494. https://doi.org/10.4103/2231-4040.107494 PMid:23662276 PMCid:PMC3645360
7. Özakar RS, Çelik B, Yenilmez E, Yazan Y. Current overview of oral thin films. Pharmaceutics. 2021;13(11):1950. https://doi.org/10.3390/pharmaceutics13111950 PMid:34834365 PMCid:PMC8618763
8. Shipp L, Liu F, Kerai-Varsani L, Okwuosa TC. Buccal films: a review of therapeutic opportunities, formulations & relevant evaluation approaches. J Control Release. 2022;352:1071-1092. https://doi.org/10.1016/j.jconrel.2022.10.058 PMid:36351519
9. Gupta MS, Ahirrao SP, Mahajan NS. Orodispersible films: conception to quality by design. Int J Pharm. 2021;607:120924. https://doi.org/10.1016/j.ijpharm.2021.120924 PMid:34324989 PMCid:PMC8579814
10. Ghourichay MP, Esfandiari N, Ghasemi S, et al. Formulation and quality control of orally disintegrating films. Int J Pharm Sci Res. 2021;12(3):1328-1339. https://doi.org/10.1155/2021/6618934 PMid:34977245 PMCid:PMC8719989
11. Kay J, Smith L, Wimmer P, et al. Simultaneous quantitation of water and residual solvents in pharmaceutical films. J Pharm Biomed Anal. 2021;197:113953. https://doi.org/10.1016/j.jpba.2021.113953 PMid:33618130
12. Ferlak J, Szymanska E, Sosnowska K, et al. Orodispersible films-current state of the art, limitations and future perspectives. Pharmaceutics. 2023;15(2):361. https://doi.org/10.3390/pharmaceutics15020361 PMid:36839683 PMCid:PMC9965071
13. Lombardo D, Kiselev MA, Caccamo MT. Amphiphiles self-assembly: basic concepts and future perspectives. Adv Colloid Interface Sci. 2015;222:124-137. https://doi.org/10.1155/2015/151683
14. Haladjova E, Rangelov S. Application of polymeric micelles for drug and gene delivery. Pharmaceutics. 2024;16(5):646. https://doi.org/10.3390/pharmaceutics16050646 PMid:38794308 PMCid:PMC11125079
15. Kotta S, Aldawsari HM, Badr-Eldin SM, Nair AB. Progress in polymeric micelles for drug delivery applications. Pharmaceutics. 2022;14(8):1636. https://doi.org/10.3390/pharmaceutics14081636 PMid:36015262 PMCid:PMC9412594
16. Hwang D, Kim J, Park E, Lee S, Yoon S. Polymeric micelles for the delivery of poorly soluble drugs. Pharmaceutics. 2020;12(6):512.
17. Weng W, Wang Q, Wei C, et al. Mixed micelles for enhanced oral bioavailability and hypolipidemic effect of liquiritin: in vitro and in vivo evaluation. Drug Dev Ind Pharm. 2021;47(8):1258-1267. https://doi.org/10.1080/03639045.2021.1879839 PMid:33494627
18. Lu H, Zhang S, Wang J and Chen Q. A Review on Polymer and Lipid-Based Nanocarriers and Its Application to Nano-Pharmaceutical and Food-Based Systems. Front. Nutr. 2021; 8:783831. https://doi.org/10.3389/fnut.2021.783831 PMid:34926557 PMCid:PMC8671830
19. Hoffmann EM, Breitenbach A, Breitkreutz J. Advances in orodispersible films for drug delivery. Eur J Pharm Biopharm. 2011;77(2):197-208. https://doi.org/10.1517/17425247.2011.553217 PMid:21284577
20. Silva BMA, Borges AF, Silva C, Coelho JFJ, Simões S. Mucoadhesive oral films: the potential for unmet needs. Int J Pharm. 2015;494(1):537-551. https://doi.org/10.1016/j.ijpharm.2015.08.038 PMid:26315122
21. Jaiswal H, Shikhande S, More DM, Kadam VJ. Recent trends in formulation of oral dissolving films: A review. Int J PharmTech Res. 2014;6(2):1054-1066.
22. Karki S, Kim H, Na SJ, Shin D, Jo K, Lee J. Thin films as an emerging platform for drug delivery. Asian J Pharm Sci. 2016;11(5):559-574. https://doi.org/10.1016/j.ajps.2016.05.004
23. Ma Y, Zhao L, Liu H, et al. Development and pharmacokinetics of an everolimus-loaded sublingual orodispersible film. Eur J Pharm Biopharm. 2020;149:19-27.
24. Aldawsari HM, Badr-Eldin SM. Formulation and evaluation of dapoxetine hydrochloride oral dissolving films for improved pharmacokinetics and patient compliance. Pharmaceutics. 2020;12(3):210.
25. Irfan M, Rabel S, Bukhtar Q, et al. Orally disintegrating films: a modern expansion in drug delivery. Saudi Pharm J. 2016;24(5):537-546. https://doi.org/10.1016/j.jsps.2015.02.024 PMid:27752225 PMCid:PMC5059831
26. Liu C, Wang Y, Luo W, et al. Fast-dissolving oral films containing luteolin nanocrystals: pharmacokinetics and bioavailability. Drug Dev Ind Pharm. 2017;43(11):1843-1851.
27. Radicioni M, Cattaneo C, Ronchi L, et al. Comparative bioavailability of vitamin D₃ orally disintegrating film versus solution. Nutrients. 2022;14(10):2005.
28. Liu W, Wang Y, Lou Y, Zhang J, Zhang L, Guo R, Zhang Q. Design and evaluation of orally dissolving films: a novel strategy for stable delivery of moisture-sensitive drugs. Drug Dev Ind Pharm. 2017;43(5):828-838. doi:10.1080/03639045.2016.1267855.
29. Pacheco MS, Barbieri D, da Silva CF, de Moraes MA. A review on orally disintegrating films (ODFs) made from natural polymers such as pullulan, maltodextrin, starch, and others. Int J Biol Macromol. 2021;178:504-513. https://doi.org/10.1016/j.ijbiomac.2021.02.180 PMid:33647337
30. He Y, Cheng X, Wang Q, Liu Y, et al. Stabilization of vitamin B12 in oral dissolving films using xanthan and pullulan. Drug Dev Ind Pharm. 2021;47(5):775-784. doi:10.1080/03639045.2021.1901589.
31. Qin Z-Y, Jia X-W, Liu Q, Kong B-H, Wang H. Fast dissolving oral films for drug delivery prepared from chitosan/pullulan electrospinning nanofibers. Int J Biol Macromol. 2019;137:224-231. https://doi.org/10.1016/j.ijbiomac.2019.06.224 PMid:31260763
32. Chen L-H, Doyle PS. Thermogelling hydroxypropyl methylcellulose nanoemulsions as templates to formulate poorly water-soluble drugs into oral thin films containing drug nanoparticles. Chem Mater. 2022;34(11):5194-5205. https://doi.org/10.1021/acs.chemmater.2c00801
33. Silvestre SM, Pereira AR, Sousa JM, et al. Orally dissolving films as patient-friendly dosage forms: formulation strategies for incorporating vitamins and supplements. Pharmaceutics. 2023;15(4):1082. https://doi.org/10.3390/pharmaceutics15041082 PMid:37111568 PMCid:PMC10145306
34. Takashima Y, Nishikawa M, Ueda H, et al. Development of oral dissolving films for delivery of prescription drugs: physicochemical properties and patient acceptability. Drug Dev Ind Pharm. 2022;48(9):197-205. doi:10.1080/03639045.2022.2034025
35. Batista P, Silva AC, Fernandes C. Overview of oral thin films for nutrient and supplement delivery: formulation and regulatory trends. J Drug Deliv Sci Technol. 2023;80:104110. https://doi.org/10.1016/j.jddst.2022.104110
36. Cupone I, Brunetti L, Musazzi UM, Selmin F, Minghetti P. Orodispersible polymeric films containing nutraceuticals: manufacturing approaches and characterization. Int J Pharm. 2023;636:122756. doi:10.1016/j.ijpharm.2023.122756.
37. Mazumder S, Pavurala N, Manda P, Xu X, Cruz CN, Krishnaiah YSR. Quality by design approach for studying the impact of formulation and process variables on product quality of oral disintegrating films. Int J Pharm. 2017;527(1-2):151-160. https://doi.org/10.1016/j.ijpharm.2017.05.048 PMid:28549972
38. Shojaee Kang Sofla M, Mortazavi S, Seyfi J. Preparation and characterization of polyvinyl alcohol/chitosan blends plasticized and compatibilized by glycerol/polyethylene glycol. Carbohydr Polym. 2020;232:115784. https://doi.org/10.1016/j.carbpol.2019.115784 PMid:31952592
39. Abou-Taleb H, El-Zahaby SA, Abdelrahim MEA. Sweeteners as taste-masking agents in orodispersible vardenafil films. Pharmaceutics. 2022;14(6):1229. https://doi.org/10.3390/pharmaceutics14030517 PMid:35335893 PMCid:PMC8951028
40. Shruthi BK, Chandrakala V, Srinivasan S. Role of Super Disintegrants in Rapid Dissolving Oral Films. Int J Pharm Sci Rev Res. 2022;75(2):110-116. https://doi.org/10.47583/ijpsrr.2022.v75i02.018
41. Desai PM, Liew CV, Heng PWS. Review of disintegrants and the disintegration phenomena. J Pharm Sci. 2016;105(9):2545-2555. https://doi.org/10.1016/j.xphs.2015.12.019 PMid:27506604
42. Panraksa P, Tipduangta P, Jantanasakulwong K, Jantrawut P. Formulation of orally disintegrating films as an amorphous solid solution of a poorly water-soluble drug. Membranes. 2020;10(12):376. https://doi.org/10.3390/membranes10120376 PMid:33261025 PMCid:PMC7759778
43. Alghaith AF, Alshahrani SM, Almehmadi MM, et al. Plasticizers in oral thin films: influence on mechanical strength and dissolution rate. Int J Pharm Sci Rev Res. 2022;72(1):45-54.
44. Baskaran R, Madheswaran T, Sundaramoorthy P, Kim HM, Yoo BK. Novel chitosan-based polymeric films for oral drug delivery. Carbohydr Polym. 2017;157:1800-1808.
45. Cheng X, Wang Q, Liu Y, et al. Stabilization of vitamin B12 in oral dissolving films using xanthan and pullulan. Drug Dev Ind Pharm. 2021;47(5):775-784.
46. Lambros M, Tran TH, Fei Q, Nicolaou M. Citric Acid: A Multifunctional Pharmaceutical Excipient. Pharmaceutics. 2022;14(5):972. https://doi.org/10.3390/pharmaceutics14050972 PMid:35631557 PMCid:PMC9148065
47. Wexler C, Patel A, Bhatt J, Narang AS. Patient acceptability and pharmacological implications of oral thin films: a review. J Drug Deliv Sci Technol. 2023;81:104327. https://doi.org/10.1016/j.jddst.2023.104327
48. Heinemann RJB, Carvalho RA, Favaro-Trindade CS. Orally disintegrating film (ODF) for delivery of probiotics in the oral cavity - development of a novel product for oral health. Innov Food Sci Emerg Technol. 2013;19:227-232. https://doi.org/10.1016/j.ifset.2013.04.009
49. Yu X, Wang L, Zhang H, Li J, Chen Y, Zhao Y. Curcumin oral thin films for improved solubility and patient compliance. J Pharm Innov. 2022;17(4):995-1007. doi:10.1007/s12247-021-09667-2.
50. Bartlett AL, Zhang G, Wallace G, Gordon CM, Freishtat RJ, Reynolds JC, et al. Optimized vitamin D repletion with oral thin-film cholecalciferol. Pediatr Transplant. 2023;27(4):e14936. doi:10.1111/petr.14936.
51. Trimaille T, Morin L, Dubois C, Brossard P-M, Couvreur P. Micellar nanocarriers: design, drug-loading, and stimuli-responsive release. Adv Drug Deliv Rev. 2023;192:114620. https://doi.org/10.1016/j.addr.2022.114620 PMid:36379406
52. Kato Y, Nishiyama N, Bae Y, Fukushima S, Yasuoka A, Koyama H, et al. Novel block copolymer micelles for drug delivery: design and behavior. J Control Release. 2007;124(1-2):43-50. https://doi.org/10.1016/j.jconrel.2007.08.006 PMid:17826863 PMCid:PMC2196406
53. Ghezzi M, Pescina S, Padula C, et al. Polymeric micelles in drug delivery: an insight into techniques for their characterization and assessment in biorelevant conditions. J Control Release. 2021;332:312-336. https://doi.org/10.1016/j.jconrel.2021.02.031 PMid:33652113
54. Zhou Z, Li Y, Wang S, et al. Smart polymeric micelles for targeted and controlled drug delivery. Eur J Pharm Biopharm. 2018;128:112-125.
55. Nakayama M, Akimoto J, Okano T. Polymeric micelles with stimuli-triggering systems for advanced cancer drug targeting. J Drug Target. 2014;22(7):584-599. https://doi.org/10.3109/1061186X.2014.936872 PMid:25012066
56. Jhaveri AM, Torchilin VP. Multifunctional polymeric micelles for delivery of drugs and siRNA. Front Pharmacol. 2014;5:77. https://doi.org/10.3389/fphar.2014.00077 PMid:24795633 PMCid:PMC4007015
57. Prencipe G, Sardo C, De Tursi M, Leone C, Favia P, Centrone M, et al. Polymeric micelles decorated with targeting bioactive moieties as drug delivery systems in precision medicine. Molecules. 2021;26(13):4049. https://doi.org/10.3390/molecules26134049 PMid:34279392 PMCid:PMC8271712
58. Wang Y, Lin M, Fan T, Zhou M, Yin R, Wang X. Advances of stimuli-responsive amphiphilic copolymer micelles in tumor therapy. Int J Nanomedicine. 2025;20:1-24. https://doi.org/10.2147/IJN.S495387 PMid:39776491 PMCid:PMC11700880
59. Qiu N, Wang H, Li Y, Zhou Z, Zhao Y, Pan F, et al. A review of stimuli-responsive polymeric micelles for tumour therapy. J Drug Target. 2021;29(9):971-986. doi:10.1080/1061186X.2021.1934869.
60. Li Y, Xiao K, Zhu W, Deng W, Lam KS. Stimuli-responsive cross-linked micelles for on-demand drug delivery against cancers. Adv Drug Deliv Rev. 2014;66:58-73. https://doi.org/10.1016/j.addr.2013.09.008 PMid:24060922 PMCid:PMC3947689
61. Rao NV, Ko H, Lee J, Park JH. Recent progress and advances in stimuli-responsive polymers for cancer therapy. Front Bioeng Biotechnol. 2018;6:110. https://doi.org/10.3389/fbioe.2018.00110 PMid:30159310 PMCid:PMC6104418
62. Cao Z, Zhao M, Wu W, et al. Recent progress in stimuli-responsive polymeric micelles for drug delivery. Prog Polym Sci. 2024;146:101749. doi:10.1016/j.progpolymsci.2024.101749
63. Younis MA, Bnyan R, Railkar A, et al. Clinical translation of nanomedicines: challenges, opportunities, and strategies. Adv Drug Deliv Rev. 2022;181:114078. https://doi.org/10.1016/j.addr.2021.114078 PMid:34896131
64. Ahmed T, Liu FCF, Wu XY. An update on strategies for optimizing polymer-lipid hybrid nanoparticle-mediated drug delivery: exploiting transformability and bioactivity of PLN and harnessing intracellular lipid transport mechanism. Expert Opin Drug Deliv. 2024;21(2):245-278. https://doi.org/10.1080/17425247.2024.2318459 PMid:38344771
65. Hassan AAA, Ramadan E, Kristó K, Regdon Jr G, Sovány T. Lipid-polymer hybrid nanoparticles as a smart drug delivery platform: synthesis, characterization and oral delivery applications. Pharmaceutics. 2025;16(5):646. https://doi.org/10.3390/pharmaceutics16050646 PMid:38794308 PMCid:PMC11125079
66. Gajbhiye V, Khopade AJ, Jain NK. Polymeric-lipid hybrid micelles: an emerging platform for drug and gene delivery. Pharmaceutics. 2023;15(4):1102. https://doi.org/10.3390/pharmaceutics15041102 PMid:37111588 PMCid:PMC10142540
67. Perumal S, Atchudan R, Lee W. A review of polymeric micelles and their applications. Polymers. 2022;14(12):2510. https://doi.org/10.3390/polym14122510 PMid:35746086 PMCid:PMC9230755
68. Lu Y, Yue Z, Xie J, Wang W, Zhu H, Zhang E, et al. Micelles with ultralow critical micelle concentration as carriers for drug delivery. Nat Biomed Eng. 2018;2(5):318-325. https://doi.org/10.1038/s41551-018-0234-x PMid:30936455 PMCid:PMC6553490
69. Zeng Y, Li S, Chen X, et al. Soluplus® micelles for improving the oral bioavailability of scopoletin. Acta Pharm Sin B. 2017;7(2):162-169.
70. Guembe-Michel N, Nguewa P, González-Gaitano G. Soluplus®-based pharmaceutical formulations: recent advances in drug delivery and biomedical applications. Int J Mol Sci. 2025;26(4):1499. https://doi.org/10.3390/ijms26041499 PMid:40003966 PMCid:PMC11855892
71. Torchilin VP. Structure and design of polymeric surfactant-based drug delivery systems. J Control Release. 2001;73(2-3):137-172. https://doi.org/10.1016/S0168-3659(01)00299-1 PMid:11516494
72. Cabral H, Kataoka K. Progress of drug-loaded polymeric micelles into clinical studies. J Control Release. 2014;190:465-476. https://doi.org/10.1016/j.jconrel.2014.06.042 PMid:24993430
73. Cagel M, Tesán FC, Bernabeu E, Salgueiro MJ, Zubillaga MB, Moretton MA, Chiappetta DA. Polymeric mixed micelles as nanomedicines: achievements and perspectives. Eur J Pharm Biopharm. 2017;113:211-228. https://doi.org/10.1016/j.ejpb.2016.12.019 PMid:28087380
74. Chougale R, Patil K, Disouza J, Hajare A, Jadhav N, Kumbhar P, et al. Development of docetaxel-loaded (Soluplus®-PF108) mixed micelles vacuum foam-dried product for improved stability and melanoma treatment by QbD approach. Futur J Pharm Sci. 2024;10:54. https://doi.org/10.1186/s43094-024-00619-z
75. Feng S, Zhang Z, Almotairy A, Repka MA. Development and evaluation of polymeric mixed micelles prepared using hot-melt extrusion for extended delivery of poorly water-soluble drugs. J Pharm Sci. 2023;112(11):2869-2878. https://doi.org/10.1016/j.xphs.2023.06.007 PMid:37327994
76. Gerardos AM, Balafouti A, Pispas S. Mixed copolymer micelles for nanomedicine. Materials (Basel). 2023;15(2):2015. https://doi.org/10.3390/nanomanufacturing3020015
77. Negut I, Bita B. Polymeric micellar systems - a special emphasis on "smart" drug delivery. Pharmaceutics. 2023;15(3):976. https://doi.org/10.3390/pharmaceutics15030976 PMid:36986837 PMCid:PMC10056703
78. Duong VA, Tran MH, Phan TTK, Nguyen TTH. Inhibition of P-glycoprotein efflux and enhancement of drug absorption in oral nanocarriers: current status and future directions. Pharmaceutics. 2021;13(8):1227. https://doi.org/10.3390/pharmaceutics13081227 PMid:34452188 PMCid:PMC8398642
79. Sun S, Zheng T, Wu Y, Zhang Y, Zhou Q. Mixed polymer-lipid micelles of PEG-PLA/TPGS for enhanced oral delivery of galactosamine-modified drug: effects on absorption and epithelial transport. Int J Pharm. 2021;603:120699. https://doi.org/10.1016/j.ijpharm.2021.120699 PMid:33992713
80. Piazzini V, Landucci E, Urru M, Chiarugi A, Pellegrini-Giampietro DE, Bilia AR, Bergonzi MC. Enhanced dissolution, permeation and oral bioavailability of aripiprazole mixed micelles: in vitro and in vivo evaluation. Int J Pharm. 2020;583:119361. https://doi.org/10.1016/j.ijpharm.2020.119361 PMid:32334067
81. Zheng H, Bai Y, Tang G, et al. Stimuli-responsive polymeric micelles for controlled drug delivery in oncology. Adv Drug Deliv Rev. 2024;205:115-131.
82. Kataoka K, Harada A, Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev. 2001;47(1):113-131. https://doi.org/10.1016/S0169-409X(00)00124-1 PMid:11251249
83. Ahmad Z, Shah A, Siddiq M, Kraatz HB. Polymeric micelles as drug delivery vehicles. RSC Adv. 2014;4:17028-17038. https://doi.org/10.1039/C3RA47370H
84. Zhou Y, Li Y, Yuan J, Xu C, Li J, Kang C, et al. Mixed polymeric micelles for drug delivery: preparation, characterization and applications. J Control Release. 2018;272:74-87. https://doi.org/10.1016/j.jconrel.2018.01.005 PMid:29331580
85. Trimaille T. Copolymer micelles: a focus on recent advances for protein/peptide delivery. Pharmaceutics. 2023;15(10):2481. https://doi.org/10.3390/pharmaceutics15102481 PMid:37896241 PMCid:PMC10609739
86. Mukherjee A, Waters AK, Kalyan P, Achrol AS, Kesari S, Yenugonda VM. Lipid-polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives. Int J Nanomedicine. 2019;14:1937-1952. https://doi.org/10.2147/IJN.S198353 PMid:30936695 PMCid:PMC6430183
87. Neguț I, Bita AI. Polymeric micelles: tumor targeting and delivery. Pharmaceutics. 2023;15(4):1129. https://doi.org/10.3390/pharmaceutics15030976 PMid:36986837 PMCid:PMC10056703
88. Kabanov AV, Batrakova EV, Alakhov VY. Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J Control Release. 2002;82(2-3):189-212. https://doi.org/10.1016/S0168-3659(02)00009-3 PMid:12175737
89. Gaucher G, Dufresne MH, Sant VP, Kang N, Maysinger D, Leroux JC. Block copolymer micelles: preparation, characterization and application in drug delivery. J Control Release. 2005;109(1-3):169-188. https://doi.org/10.1016/j.jconrel.2005.09.034 PMid:16289422
90. Porter CJH, Pouton CW, Cuine JF, Charman WN. Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv Drug Deliv Rev. 2008;60(6):673-691. https://doi.org/10.1016/j.addr.2007.10.014 PMid:18155801
91. Zhao Y, Wang C, Chow AH-L, Ren K, Gong T, Zhang Z, et al. Stable phosphatidylcholine-bile salt mixed micelles to enhance intestinal absorption of paclitaxel in rats. Int J Pharm. 2014;473(1-2):474-484. https://doi.org/10.1016/j.ijpharm.2014.07.027 PMid:25066077
92. Kotake-Nara E, Komba S, Hase M. Uptake of vitamins D2, D3, D4, D5, D6, and D7 solubilized in mixed micelles by human intestinal cells, Caco-2, and an enhancing effect of lysophosphatidylcholine on the cellular uptake. Nutrients. 2021;13(5):1555. https://doi.org/10.3390/nu13051555 PMid:34063058 PMCid:PMC8147969
93. Saxena V, Delwar Hussain M. Polymeric mixed micelles for delivery of curcumin to multidrug resistant ovarian cancer. J Biomed Nanotechnol. 2013;9(7):1146-1153. https://doi.org/10.1166/jbn.2013.1632 PMid:23909128
94. Islam N, Irfan M, Khan SU, Syed HK, Iqbal MS, Khan IU, Mahdy A, Raafat M, Hossain MA. Poloxamer-188 and d-α-tocopheryl polyethylene glycol succinate (TPGS-1000) mixed micelles integrated into orodispersible sublingual films to improve oral bioavailability of ebastine. Pharmaceutics. 2021;13(1):54. https://doi.org/10.3390/pharmaceutics13010054 PMid:33406587 PMCid:PMC7823785
95. Wei Z, Zhu D, Ma Y, Wen Y, Wang Z, Li L. Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vivo evaluation. Int J Pharm. 2009;373(1-2):189-196. https://doi.org/10.1016/j.ijpharm.2009.03.036 PMid:19428198
96. Bae Y, Nishiyama N, Fukushima S, Koyama H, Matsumura Y, Kataoka K. Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy. Bioconjug Chem. 2005;16(1):122-130. https://doi.org/10.1021/bc0498166 PMid:15656583
97. Han Y, Li J, Zan M, Luo S, Ge Z, Liu S. Redox-responsive core cross-linked micelles based on cypate- and cisplatin-prodrug-conjugated block copolymers for synergistic photothermal-chemotherapy of cancer. Polym Chem. 2014;5(12):3707-3719. https://doi.org/10.1039/C4PY00064A
98. Nasongkla N, Shuai X, Ai H, Weinberg BD, Pink J, Boothman DA, et al. cRGD-functionalized polymer micelles for targeted doxorubicin delivery. Angew Chem Int Ed. 2004;43(46):6323-6327. https://doi.org/10.1002/anie.200460800 PMid:15558662
99. Peng J, Qi T, Liao J, Chu X, Wu Q, Guo X, et al. Herceptin-conjugated paclitaxel-loaded PCL-PEG worm-like micelles for HER2-positive breast cancer therapy. J Control Release. 2019;311-312:136-149. https://doi.org/10.1016/j.jconrel.2019.08.001 PMid:31381942
100. Cai Y, et al. The in vivo fate of polymeric micelles. J Control Release. 2022;349:640-658. https://doi.org/10.1016/j.jconrel.2022.03.032 PMid:35331783 PMCid:PMC8935967
101. Zhang W, Shi Y, Chen Y, Yu S, Hao J, Luo J. Enhanced antitumor efficacy by paclitaxel-loaded mixed micelles composed of Pluronic P123 and D-α-tocopheryl polyethylene glycol succinate 1000. Mol Pharm. 2019;16(3):1072-1084.
102. Tyrrell ZL, Shen Y, Radosz M. Fabrication of micellar nanoparticles for drug delivery through the self-assembly of block copolymers. Prog Polym Sci. 2010;35(9):1128-1143. https://doi.org/10.1016/j.progpolymsci.2010.04.002
103. Zhang L, Li X, Zhao H, et al. Antisolvent precipitation for improving solubility and dissolution of poorly water-soluble drugs: strategies and recent advances. Eur J Pharm Sci. 2022;170:106122. https://doi.org/10.1016/j.ejps.2022.106122 PMid:35007712
104. Jaiswal H, Shikhande S, More DM, Kadam VJ. Recent trends in formulation of oral dissolving films: A review. Int J PharmTech Res. 2014;6(2):1054-1066.
105. Chou WH, Galaz A, Jara MO, Gamboa A, Morales JO. Drug-loaded lipid-core micelles in mucoadhesive films as a novel dosage form for buccal administration of poorly water-soluble and biological drugs. Pharmaceutics. 2020;12(12):1168. https://doi.org/10.3390/pharmaceutics12121168 PMid:33266132 PMCid:PMC7761273
106. Prajapati BG, Patel MM, et al. Mixed micelle sublingual films of curcumin for enhanced bioavailability. Drug Dev Ind Pharm. 2023;49(1):1-10.
107. Chen K, Sun Y. Development and optimization of oral dissolution films for enhanced delivery of ebastine-loaded solid lipid nanoparticles. Int J Nanomedicine. 2025;20:6963-6981. https://doi.org/10.2147/IJN.S521504 PMid:40462833 PMCid:PMC12132053
108. Patel C, Pujari R, Rede P, Prajapati B, Dharamsi A. The electro-spun sublingual film containing curcumin micelles. J Nat Remedies. 2023;23(1):206-213.
109. Elshafeey AH, El-Dahmy RM. Formulation and development of oral fast-dissolving films loaded with nanosuspension to augment paroxetine bioavailability: in vitro characterization, ex vivo permeation, and pharmacokinetic evaluation in healthy human volunteers. Pharmaceutics. 2021;13(11):1869. https://doi.org/10.3390/pharmaceutics13111869 PMid:34834284 PMCid:PMC8620498
110. Nagar P, Chauhan I, Yasir M. Insights into polymers: film formers in mouth dissolving films. Drug Invent Today. 2011;3(12):280-289.
111. Hussain Z, Pandey M, Chauhan M, et al. Optimization of solvent casting parameters for polymeric micelle-loaded oral films. J Drug Deliv Sci Technol. 2023;79:104012.
112. Ferlak J, Krupa A, Stompor-Gorący M. Orodispersible films-current state of the art, limitations and future directions. Pharmaceutics. 2023;15(2):361. https://doi.org/10.3390/pharmaceutics15020361 PMid:36839683 PMCid:PMC9965071
113. Steiner D, Pfaffenbach J, Brandl M. Orodispersible films: a delivery platform for solid lipid nanoparticles. Pharmaceutics. 2021;13(12):2162. https://doi.org/10.3390/pharmaceutics13122162 PMid:34959444 PMCid:PMC8709056
114. Tzanova MM, Kassarova MI, Ginevskaya VT, Tzankova V. Solid lipid nanoparticle-loaded mucoadhesive buccal films. Int J Pharm. 2021;599:120420. https://doi.org/10.1016/j.ijpharm.2021.120420 PMid:33647404
115. Kumar R, et al. Mucoadhesive carriers for oral drug delivery. Adv Drug Deliv Rev. 2022;187:114360. https://doi.org/10.1016/j.addr.2022.114360 PMid:35636568
116. Sandri G, et al. The role of chitosan as a mucoadhesive agent in mucosal drug delivery. J Drug Deliv Sci Technol. 2012;22(5):275-284. https://doi.org/10.1016/S1773-2247(12)50046-8
117. Alaei S, et al. Mucoadhesion and mechanical assessment of oral films. J Pharm Pharm Sci. 2021;24:1-20. doi:10.18433/jpps31815.
118. Jacob S, Nair AB, Shah J. An updated overview of the emerging role of patch and film-based buccal delivery systems. Pharmaceutics. 2021;13(8):1206. https://doi.org/10.3390/pharmaceutics13081206 PMid:34452167 PMCid:PMC8399227
119. Mahmood A, Lanthaler M, Laffleur F, Bernkop-Schnürch A. Thiolated polymeric micelles: Highly mucoadhesive drug carrier systems. Eur J Pharm Biopharm. 2017;115:102-108. https://doi.org/10.1016/j.ejpb.2017.02.014 PMid:28232106
120. Dyawanapelly S, Dandekar P, Jain R, Tiwari D, Sharma S, Belgamwar V, et al. Improved oral bioavailability of curcumin using thiolated chitosan nanoparticles: role of mucoadhesion and efflux transport inhibition. Drug Deliv Transl Res. 2016;6(4):420-431. https://doi.org/10.1007/s13346-016-0295-x PMid:27106502
121. Bernkop-Schnürch A, Dünnhaupt S. Chitosan-based drug delivery systems. Eur J Pharm Biopharm. 2010;74(2):251-256. https://doi.org/10.1016/j.ejpb.2009.08.007 PMid:19723580
122. Torchilin VP. Micellar nanocarriers: pharmaceutical perspectives. Pharm Res. 2007;24(1):1-16. https://doi.org/10.1007/s11095-006-9132-0 PMid:17109211
123. Narang AS, Delmarre D. Oral bioavailability and stability of nanosized drug carriers. Drug Discov Today. 2021;26(3):758-769.
124. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS. Cancer Res. 1986;46(12):6387-6392.
125. Wu J. The Enhanced Permeability and Retention (EPR) Effect: The Significance of the Concept and Methods to Enhance Its Application. J Pers Med. 2021;11(8):771. https://doi.org/10.3390/jpm11080771 PMid:34442415 PMCid:PMC8402171
126. Pouton CW. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci. 2006;29(3-4):278-287. https://doi.org/10.1016/j.ejps.2006.04.016 PMid:16815001
127. Preis M, Woertz C, Kleinebudde P, Breitkreutz J. Oromucosal film preparations: classification and characterization methods. Expert Opin Drug Deliv. 2013;10(9):1303-1317. https://doi.org/10.1517/17425247.2013.804058 PMid:23768198
128. Gil MC, Park SJ, Lee BS, Park C, Lee BJ. Dual thermal stabilizing effects of xanthan gums via glycosylation and hydrogen bonding and in vivo human bioavailability of desmopressin in orodispersible film. Int J Pharm. 2023;637:122879. https://doi.org/10.1016/j.ijpharm.2023.122879 PMid:36958609
129. De'Nobili MD, Pérez AA, Andina N, Descalzo AM. Stability of L-(+)-ascorbic acid in alginate edible films: effect of film composition and storage conditions. Food Hydrocoll. 2016;58:82-90. https://doi.org/10.1016/j.foodhyd.2016.02.030
130. Emami F, Vatanara A. Recent progress in drying technologies for improving the stability of biopharmaceuticals. AAPS PharmSciTech. 2023;24(4):162. doi:10.1208/s12249-023-02514-0.
131. Myers GL, Peura RA, Stepensky D, inventors; MonoSol Rx LLC, assignee. Uniform films for rapid-dissolve dosage forms. US patent 9,855,221 B2. 2018 Jan 2.
132. Myers GL, Peura RA, Stepensky D, inventors; MonoSol Rx LLC, assignee. Uniform films for rapid-dissolve dosage forms. US patent 8,603,514 B2. 2013 Dec 10.
133. Jacob S, Nair AB, Shah J. Orodispersible films: current innovations and emerging trends. Pharmaceutics. 2023;15(1):52. https://doi.org/10.3390/pharmaceutics15010052 PMid:36678681 PMCid:PMC9861000
134. Takeuchi Y, Kato T, Karasawa K. Orally disintegrating films: the effects of water content on mechanical properties. Int J Pharm X. 2021;3:100100. https://doi.org/10.1016/j.jddst.2021.102893
135. Janigová N, Elbl J, Pavloková S, Gajdziok J. Effects of various drying times on the properties of 3D-printed orodispersible films. Pharmaceutics. 2022;14(2):250. https://doi.org/10.3390/pharmaceutics14020250 PMid:35213983 PMCid:PMC8878870
136. Abbot V, Sharma P, Sharma A, Sharma D, Sharma T. Micelles transforming modern medicine: a comprehensive review on the role of micellar physicochemical properties in improving flavonoid bioavailability and neomycin efficacy. Discover Chemistry. 2025;2:220. https://doi.org/10.1007/s44371-025-00292-y
137. Varun S, Keerthy HS. Innovative strategies in the formulation and applications of mouth dissolving films for enhanced oral drug delivery. Drug Dev Ind Pharm. 2025; [Epub ahead of print]. https://doi.org/10.1080/03639045.2025.2510581 PMid:40411319
138. Reis CP, Neves AR, Segundo MA. Nanomedicine regulatory and safety challenges: lessons from current pharmaceutical development. Pharmaceutics. 2022;14(7):1449. https://doi.org/10.3390/pharmaceutics14071449 PMid:35890343 PMCid:PMC9323949
139. Sato H, Yamada K, Miyake M, Onoue S. Recent advancements in the development of nanocarriers for mucosal drug delivery systems to control oral absorption. Pharmaceutics. 2023;15(12):2708. https://doi.org/10.3390/pharmaceutics15122708 PMid:38140049 PMCid:PMC10747340
140. Hwang D, Ramsey JD, Kabanov AV. Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. Adv Drug Deliv Rev. 2020;156:80-118. https://doi.org/10.1016/j.addr.2020.09.009 PMid:32980449 PMCid:PMC8173698
141. Sosnik A. Polymeric micelles in mucosal drug delivery: challenges towards clinical translation. Biotechnol Adv. 2015;33(6):1818-1846. https://doi.org/10.1016/j.biotechadv.2015.01.003 PMid:25597531
142. Elbl J, Veselý M, Blaháčková D, Ondruš J, Kulich P, Mašková E, Mašek J, Gajdziok J. Development of 3D printed multi-layered orodispersible films with porous structure applicable as a substrate for inkjet printing. Pharmaceutics. 2023;15(2):714. https://doi.org/10.3390/pharmaceutics15020714 PMid:36840036 PMCid:PMC9961792
Published
Abstract Display: 169 
PDF Downloads: 100 PDF Downloads: 28 How to Cite
Issue
Section
Copyright (c) 2025 Katharine H. Cole, Pankaj Modi
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.